Kyndryl Holdings, Inc. Key Metrics

2 years of history · ending 2025-03-31 · SEC EDGAR

Forensics

Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.

F-Score (Piotroski 0-9)

M-Score (Beneish; >-1.78 flags risk)

Per Share Metrics

Turnover & Efficiency Analysis (days)

Expense Ratios

Working Capital Analysis

Valuation Multiples

Cash-Flow Multiples

Enterprise Value Multiples

52-Week Range

Trailing Returns

ROIC vs WACC

Yields

Capital Deployment Yields

Liquidity & Leverage Ratios

Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)

EPS (Diluted)
$1
Book Value Per Share
$5
Free Cash Flow Per Share
$1
Cash Per Share
$7
Revenue Per Share
$63
OCF Per Share
$4
Return on Equity
21.5%
Return on Assets
2.4%
Debt to Equity
2.38
Current Ratio
1.07
Quick Ratio
1.07
Asset Turnover
1.43
Days Sales Outstanding
32.60
Days Payables Outstanding
41.39
R&D / Revenue
0.3%
SBC / Revenue
0.7%
Capex / Revenue
4.0%
Working Capital
$289M
Net Current Asset Value
$-4.53B
Invested Capital
$4.12B
OCF / Net Income
3.74
FCF / Net Income
1.34
Accruals Ratio (Sloan)
-6.6%
Net Debt
$1.24B
Net Debt / EBITDA
1.88
Cash Coverage
9.42
Capex Coverage
1.56
Tangible Common Equity
$211M
TCE / Total Assets
2.0%
Goodwill / Total Assets
7.6%
Cash ROIC
8.3%
WC / Revenue
1.9%
Capex / D&A
0.92
Total Payout Ratio
36.9%
Asset Growth vs Revenue Growth
4.9%
Revenue 5Y CAGR
-5.8%
EBITDA 5Y CAGR
-14.8%
Book Value 5Y CAGR
-27.3%
Stock Price (FY-end)
$31
Market Cap
$7.51B
P/E Ratio
29.79
P/S Ratio
0.50
P/B Ratio
6.16
P/TB Ratio
35.58
P/OCF Ratio
7.97
P/FCF Ratio
22.28
Enterprise Value
$8.75B
EV / EBITDA
13.26
EV / Sales
0.58
EV / FCF
25.97
FCF Yield
4.5%
Shareholder Yield
-0.1%
Buyback Yield
1.2%
R&D Yield
0.7%
Capex Yield
8.1%
Graham Number
$11
Shares Variation (YoY)
4.3%
Beta (5Y)
1.33
Cost of Equity
11.2%
Cost of Debt (after tax)
1.9%
WACC
8.5%
52W High
$43
52W Low
$19
Trailing Return 1Y
46.3%
F-Score (Piotroski)
6.00
M-Score (Beneish)
-2.99

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

EPS — Consensus vs Actual

Revenue — Consensus vs Actual

Beat / Miss vs Estimate

Stock Price on Earnings Dates

Kyndryl Holdings, Inc. — Effective Tax Rate ReconciliationNEW

Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.

Effective Rate Trend

Reconciliation LineFY2019FY2020FY2021FY2023FY2024FY2025
Federal Statutory Rate21.00%21.00%21.00%21.00%21.00%21.00%
State & Local Income Taxes6.30%2.80%3.00%5.70%17.80%0.70%
Foreign Rate Differential-18.90%-5.90%-8.60%-3.90%-17.40%4.50%
Other Adjustments-1.60%0.10%-0.20%-1.40%
Nondeductible Expenses-2.00%-8.60%1.90%
Valuation Allowance Change-59.10%-26.10%-16.10%-72.00%-67.70%-4.10%
Effective Tax Rate-62.90%-14.00%-21.10%-61.60%-102.20%41.90%

Cash vs Accrual

ItemFY2019FY2020FY2021FY2023FY2024FY2025
Income Tax Expense (Accrual)$364.0M$247.0M$402.0M$524.0M$172.0M$184.0M
Income Taxes Paid (Cash)$12.0M$167.0M$191.0M$149.0M

Kyndryl Holdings, Inc. — M&A AcquisitionsNEW

Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.

Skytap Inc

Purchase-Price Allocation

Goodwill

$11.0M

Liabilities Assumed

$29.0M

Kyndryl Holdings, Inc. — RestructuringNEWReversal

Per-category restructuring disclosures sourced from us-gaap:RestructuringCostAndReserveAxis dimensional XBRL. Negative charges indicate reversals of prior accruals (a sign the original estimate was too aggressive — flattering current-period earnings).

As of 2025-12-31

CategoryClassP&L ChargeCash PaidReserve Balance
Workforce Rebalancing ChargesOther+$114M$25M$16M
Charges Related To Ceasing To Use Leased And Fixed AssetsFacility Closing+$48M
Charges Related To Ceasing To Use Leased AssetsFacility Closing+$39M
Abandonment Of Certain Company Owned Fixed AssetsAsset Impairment / Write-Down+$8M
Charges Related To Ceasing To Use Fixed AssetsAsset Impairment / Write-Down+$8M$5M
Charges Related To One Off TerminationsContract Termination+$4M
Workforce Rebalancing Liabilities Inherited From Former ParentOther+$4M$14M$16M
Charges Related To Lease TerminationsFacility Closing−$1M$2M$3M